An overview of changing aspects for national Phase I trials under the EU Clinical Trial Regulation (13 MAY 2022)
1. Ingrid Klingmann_Introduction.pdf
2.1 Sebastien Vanhiesbecq_CT College_BE
2.2 Thomas Sudhop_BfARM
2.3 Claire Bahans_CNCP
2.4 Anne Moulin_MDSS
2.5 Pieter de Graeff_BEBO
Read more about the 2022 CTIS Webinar 1 here!
Previous Post
Next Post
EUFEMED
Square de Meeûs 35
1000 Brussels
Belgium
